Regenxbio Inc (NAS:RGNX)
$ 8.92 0.16 (1.83%) Market Cap: 440.86 Mil Enterprise Value: 228.13 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 65/100

Regenxbio Inc KOL Conference Call to Discuss RGX-314 Data Presentations Transcript

Oct 01, 2021 / 09:00PM GMT
Release Date Price: $40.28 (-3.91%)

Oct 01, 2021 / 09:00PM GMT
Presentations
Oct 01, 2021 / 09:00PM GMT

=====================
Corporate Participants
=====================
* Kenneth T. Mills
REGENXBIO Inc. - President, CEO & Director
* Patrick J. Christmas
REGENXBIO Inc. - Senior VP & Chief Legal Officer
* Stephen Pakola
REGENXBIO Inc. - Senior VP & Chief Medical Officer

=====================
Conference Call Participants
=====================
* Alec Warren Stranahan
BofA Securities, Research Division - Associate
* Dane Vincent Leone
Raymond James & Associates, Inc., Research Division - Research Analyst
* Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director
* Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
* Luca Issi
RBC Capital Markets, Research Division - Research Analyst
* Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst
* Vikram Purohit
Morgan Stanley,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot